Report on global development of antitumor drugs (2016)
文献类型：期刊论文
| 作者 | Mao Yanyan; Gao Liubin
|
| 刊名 | Science & Technology Review
 |
| 出版日期 | 2016 |
| 卷号 | 34期号:11页码:21-24 |
| 关键词 | tumor drug research and development monoclonal antibodies protein kinase |
| ISSN号 | 1000-7857 |
| 其他题名 | 全球抗肿瘤药物研发报告(2016) |
| 文献子类 | Review |
| 英文摘要 | The treatment of cancer patients is a world-wide problem. Antitumor drugs, as one of the most important treatments for cancer patients, see a rapid growth in recent years with various institutions working in different indications and targets each year. Based on literature research and database retrieval, the global antitumor drug number, the development stages, the indications and the mechanisms, as well as research institutions and sales, are reviewed in this paper, focusing on the general trend and direction of the antitumor drug development. |
| WOS研究方向 | Pharmacology & Pharmacy (provided by Clarivate Analytics) |
| 语种 | 中文 |
| CSCD记录号 | CSCD:5736252 |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/269250]  |
| 专题 | 信息中心 |
| 通讯作者 | Mao Yanyan; Gao Liubin |
| 作者单位 | Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. |
| 推荐引用方式 GB/T 7714 | Mao Yanyan,Gao Liubin. Report on global development of antitumor drugs (2016)[J]. Science & Technology Review,2016,34(11):21-24. |
| APA | Mao Yanyan,&Gao Liubin.(2016).Report on global development of antitumor drugs (2016).Science & Technology Review,34(11),21-24. |
| MLA | Mao Yanyan,et al."Report on global development of antitumor drugs (2016)".Science & Technology Review 34.11(2016):21-24. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。